Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS

Description

The objective of the randomized, sham-controlled trial will be to evaluate the effectiveness of treatment with transcutaneous electrical nerve stimulation (TENS) at reducing the level of fatigue experienced by people with MS.

Conditions

Multiple Sclerosis

Study Overview

Study Details

Study overview

The objective of the randomized, sham-controlled trial will be to evaluate the effectiveness of treatment with transcutaneous electrical nerve stimulation (TENS) at reducing the level of fatigue experienced by people with MS.

Reducing Fatigue in People With Multiple Sclerosis by Treatment With Transcutaneous Electrical Nerve Stimulation

Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS

Condition
Multiple Sclerosis
Intervention / Treatment

-

Contacts and Locations

Boulder

University of Colorado, Boulder, Colorado, United States, 80309

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Men and women18-65 yrs
  • * Able to read, understand, and speak English to ensure safe participation in the project
  • * Clinical diagnosis of relapsing-remitting MS
  • * Self-reported difficulty with walking
  • * On stable doses of Ampyra, provigil, or other symptomatic-treating medications
  • * No relapse or systemic steroids within the last 30 days
  • * Able to arrange transportation to the Boulder campus
  • * Vision or hearing problems that have not been corrected
  • * Problems with sensations to temperature, pressure, or pain
  • * Any arm or leg problems that would influence the ability to hold a weight
  • * Surgery to the arms or legs that continues to bother the participant
  • * Metal implants
  • * Medical diagnosis or condition that is considered to be an absolute or relative contraindication to participating in exercise training, such as major renal, pulmonary, hepatic, cardiac, gastrointestinal, HIV, cancer (other than treated basal cell cancer), other neurological disorders, or pregnancy
  • * History of head injury or stroke
  • * Taking antidepressants, anticholinergics, stimulants, sedatives, cannabis, illicit drugs or medications to treat herpes or neurologic pain.
  • * Diagnosis of diabetes mellitus
  • * Poorly controlled hypertension
  • * History of seizure disorders
  • * ≥2 alcoholic drinks/day, or present history (last 6 months) of drug abuse
  • * Spasticity that requires the individual to change intended activities more often than once a week
  • * Skin diseases or sensation problems in the legs or hands that influences some activities more often than once a week
  • * Inability to attend exercise sessions 3 days per week for 6 weeks

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Colorado, Boulder,

Study Record Dates

2028-03